MilanEXPO/iStock via Getty Images
Abbott Laboratories (NYSE:ABT) rose 1.4% after a judge ruled in favor of the company for an upcoming trial over claims about its baby formula.
The judge granted Abbott’s (NYSE:ABT) request for summary judgment and dates for jury selection and